CTI acquires CRO based in Middle East, Africa 17-Sep-2020 By Jenni Spinner CTI Clinical Trial and Consulting Services has expanded its global reach by purchasing Clinart, a full-service CRO with precence in the MENA region.
CPhI: cell and gene therapy capacity shortages on the horizon 16-Sep-2020 By Jenni Spinner CPhI’s Annual Report 2020 predicts impending cell and gene capacity shortages for the US market, and possible mAb production growth in China.
People on the Move: July 2020 02-Jul-2020 By Jenni Spinner Our latest spotlight on new hires, promotions and awards involves Lonza, ChargePoint Technology, Ashfield, Current Health and other industry firms.
Diamond Pharma Services acquires PharmaCentral 12-May-2020 By Jenni Spinner The purchase of the Irish pharmacovigilance specialist is intended to expand’s Diamond’s European presence, and increase its senior-level industry expertise.
People on the Move: May 2020 06-May-2020 By Jenni Spinner This month’s new hires and promotions include executive appointments at Advarra, Eversana, Signant Health, Endpoint Clinical and other companies.
Advarra purchases IRBco 05-May-2020 By Jenni Spinner The institutional review board and research technology solutions provider has acquired IRBco to expand its reach and presence in North America.
3M Drug Delivery Systems relaunches as Kindeva Drug Delivery 04-May-2020 By Jenni Spinner The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.
GSK looking to sell part of antibiotics business 03-Mar-2020 By Vassia Barba GSK reportedly exploring the sale of part of its antibiotics business, as it refocuses its operations towards R&D.
Roche takes Bicycle tech for drug discovery spin 27-Feb-2020 By Ben Hargreaves Genentech and Bicycle partner for the development of small molecule, immuno-oncology targets.
Grifols picks up bankrupt antibiotics developer’s portfolio 25-Feb-2020 By Vassia Barba Grifols set to purchase all assets of Aradigm, including its Phase III antibiotic for respiratory diseases, after the developer filed for bankruptcy.
Merck KGaA sells allergy business to focus on innovative medicine 24-Feb-2020 By Ben Hargreaves Dermapharm will pick up the business unit for an unspecified fee, whilst Merck will retain the development of its adrenaline autoinjector project.
Dr Reddy’s picks up portfolio and facility from rival for $259m 17-Feb-2020 By Ben Hargreaves Wockhardt sells part of its domestic business to fund growth in international markets and to develop its biosimilar business.
Sterling expects further HPAPI demand, looks for buy-out opportunities 15-Jan-2020 By Vassia Barba Sterling continues expansion and lines up further acquisitions, as the HPAPI market continues to see increasing demand, a company executive says.
Alcami sells Dutch API facility to MercachemSyncom 14-Jan-2020 By Ben Hargreaves Alcami downsizes in Europe through the sale of its API facility to MercachemSyncom, as it expands its presence in North America.
ANI picks up US generics portfolio of Amerigen 13-Jan-2020 By Ben Hargreaves ANI acquires the 23 generic products from Amerigen to expand its commercial offering in the US.
